ACTG director granted 6,438 shares as Q2 fees

Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.

ACACIA RESEARCH CORP director Gavin Molinelli received 6,438 shares of common stock on June 30, 2026, as a grant in lieu of cash for Q2 2026 director fees. The grant was priced at $4.66 per share and increased his direct holdings to 205,966 shares of common stock. This was a compensation-related share award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 6,438 shares

Grant/Award 1 txn

Insider Molinelli Gavin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.001	6,438	$4.66	$30K

Holdings After Transaction: Common Stock, par value $0.001 — 205,966 shares (Direct)

Footnotes (1)

1. F1. Grant of shares of Common Stock in lieu of cash for Q2 2026 director fees.

Key Figures

Shares granted: 6,438 shares Grant price: $4.66 per share Holdings after transaction: 205,966 shares +2 more

5 metrics

Shares granted 6,438 shares Common Stock grant on June 30, 2026

Grant price $4.66 per share Value used for the Q2 2026 director fee stock grant

Holdings after transaction 205,966 shares Total direct common stock held by Gavin Molinelli after grant

Transaction code A Grant, award, or other acquisition of non-derivative common stock

Transaction direction acquire Compensation-related share award, not an open-market purchase

Key Terms

Grant, award, or other acquisition, in lieu of cash, director fees, Common Stock, par value $0.001

4 terms

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

in lieu of cash financial

"Grant of shares of Common Stock in lieu of cash for Q2 2026 director fees."

director fees financial

"in lieu of cash for Q2 2026 director fees."

Common Stock, par value $0.001 financial

"security_title": "Common Stock, par value $0.001""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ACTG director Gavin Molinelli report?

Gavin Molinelli reported receiving a grant of 6,438 ACACIA RESEARCH CORP common shares. The award was compensation, given in stock instead of cash for Q2 2026 director fees, rather than an open-market trade.

At what price were the ACACIA RESEARCH CORP (ACTG) shares granted?

The grant to Gavin Molinelli was valued at $4.66 per ACACIA RESEARCH CORP share. This price is used for reporting the compensation value of the stock award given instead of a cash director fee payment.

How many ACTG shares does Gavin Molinelli hold after this Form 4 transaction?

Following the grant, Gavin Molinelli directly holds 205,966 ACACIA RESEARCH CORP common shares. This updated holding reflects the addition of 6,438 shares received as Q2 2026 director fee compensation in stock.

Was the ACTG Form 4 transaction a market purchase or sale?

The ACTG Form 4 shows a compensation grant, not a market trade. Shares were issued to Gavin Molinelli in lieu of cash for Q2 2026 director fees, so no open-market buying or selling occurred in this transaction.

What is the purpose of the ACTG stock grant reported for Q2 2026?

The stock grant compensates Gavin Molinelli for Q2 2026 director fees using shares instead of cash. This aligns his compensation partly with equity in ACACIA RESEARCH CORP, as indicated by the footnote describing the award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Molinelli Gavin

(Last) (First) (Middle)

777 THIRD AVENUE, 18TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACACIA RESEARCH CORP [ ACTG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001	06/30/2026		A		6,438(1)	A	$4.66	205,966	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of shares of Common Stock in lieu of cash for Q2 2026 director fees.

	/s/ Gavin T. Molinelli	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)